6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

55 trials found

diseases per page:

Showing 1 to 10 of 55 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03250117 (ClinicalTrials.gov)	October 10, 2017	11/8/2017	Relative Bioavailability Study of RopiniroleImplants in Parkinson's Patients on L-Dopa Switched From ...	An Open-Label, Relative Bioavailability Study Evaluating the Safety, Tolerability, and Pharmacokinet ...	Parkinson Disease	Drug: Ropinirole oral product;Drug: Ropinirole Implant	Titan Pharmaceuticals	NULL	Terminated	30 Years	80 Years	All	3	Phase 1/Phase 2	United States
2	JPRN-JapicCTI-152870	11/4/2015	14/04/2015	A parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA	A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L- ...	Parkinson's disease	Intervention name : HP-3000 (ropinirolehydrochloride patch) Dosage And administration of the interven ...	Hisamitsu Pharmaceutical Co.,Inc.	NULL		20	79	BOTH		Phase 3	NULL
3	JPRN-JapicCTI-142748	11/12/2014	16/12/2014	Long-term study of HP-3000 in patients with Parkinson's disease	A phase III long-term study of HP-3000 in patients with Parkinson's disease	Parkinson's disease	Intervention name : HP-3000(ropinirolehydrochloride patch) Dosage And administration of the intervent ...	Hisamitsu Pharmaceutical Co.,Inc.	NULL		20	79	BOTH		Phase 3	NULL
4	EUCTR2011-002827-17-SK (EUCTR)	17/09/2013	04/03/2013	A fixed dose, dose response study for ropiniroleprolonged release (PR) in patients with early stage ...	A fixed dose, dose response study for ropiniroleprolonged release (PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 15.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: Local Trade Name, 2mg Product Name: ropinirole PR , 2mg Product Code: SK&F101468 INN or Propo ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
5	NCT01929317 (ClinicalTrials.gov)	August 28, 2013	22/8/2013	A Study to Evaluate the Efficacy of 18 to 24mg/Day RopiniroleControlled Release (CR) Tablets in Earl ...	A Study ROP116991, Clinical Evaluation of 18 to 24mg/Day Ropinirole CR for Parkinson's Disease.	Parkinson Disease	Drug: Ropinirole CR 2mg tablet;Drug: Ropinirole CR 8mg tablet;Drug: RopiniroleCR matching Placebo tabl ...	GlaxoSmithKline	NULL	Terminated	20 Years	N/A	All	81	Phase 3	Japan
6	EUCTR2011-002828-41-EE (EUCTR)	23/04/2013	08/02/2013	A study to test the effectiveness of varying doses of ropinirolePR while taking L-dopa in patients w ...	A fixed dose, dose-response study of ropiniroleprolonged release (PR) as adjunctive treatment to L-d ...	Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR , 2mg Product Code: SK&F101468 INN or Propose ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Taiwan;Estonia;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
7	EUCTR2011-002827-17-EE (EUCTR)	23/04/2013	08/02/2013	A fixed dose, dose response study for ropiniroleprolonged release (PR) in patients with early stage ...	A fixed dose, dose response study for ropiniroleprolonged release (PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: REQUIP-MODUTAB , 2mg Product Name: ropinirole PR , 2mg Product Code: SK&F101468 INN or Propos ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
8	EUCTR2011-002828-41-SK (EUCTR)	27/03/2013	04/03/2013	A study to test the effectiveness of varying doses of ropinirolePR while taking L-dopa in patients w ...	A fixed dose, dose-response study of ropiniroleprolonged release (PR) as adjunctive treatment to L-d ...	Advanced Parkinson's disease. MedDRA version: 16.0;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: Requip Modutab, 2mg Product Name: ropinirole PR , 2mg Product Code: SK&F101468 INN or Propose ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Estonia;Taiwan;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
9	EUCTR2012-000801-64-GB (EUCTR)	09/02/2013	26/11/2012	A study of the effects of medication on memory in Parkinson's Disease	A Phase IV Acceptability and Feasibility Trial of the Effects of Medication on Memory in Idiopathic ...	Idiopathic Parkinson's Disease MedDRA version: 17.0;Level: LLT;Classification code 10013113;Term: Di ...	Trade Name: Mirapexin extended release various strengths Product Name: Pramipexole dihydrochloride mono ...	University Hospital of North Staffordshire	Keele University	Not Recruiting			Female: yes Male: yes	55	Phase 4	United Kingdom
10	NCT01723904 (ClinicalTrials.gov)	October 2012	6/11/2012	A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of ...	An Open-Label Study to Investigate the Safety and Efficacy of Rotigotine Add-On Therapy With Low Dos ...	Advanced Parkinson's Disease	Drug: Rotigotine	UCB BIOSCIENCES GmbH	Otsuka Pharmaceutical Co., Ltd.	Completed	30 Years	80 Years	All	90	Phase 3	Australia;Korea, Republic of;Malaysia;Singapore;Taiwan

First Previous1 2 3 4 5 6Next Last